Overview A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019) Status: Completed Trial end date: 2003-02-01 Target enrollment: Participant gender: Summary The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder. Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.